Camcolit

Quick links to important sections

Camcolit

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Camcolit

Property Description
Active ingredient Lithium carbonate
Form Modified-release tablet (controlled-release formulation)
Pharmacological class Mood stabilizer, Antimanic agent
Common use Long-term emotional regulation and stability
Origin Synthetic inorganic salt preparation

What Type of Medicine is Camcolit?

Camcolit is a prescription-only medicine (POM) formally classified as a psychotropic agent and a mood stabilizer. This oral preparation is fundamentally intended to influence the central nervous system (CNS) to promote emotional regulation.

The drug's active component is Lithium carbonate, an inorganic salt preparation derived from the naturally occurring alkali metal ion, Lithium. This unique chemical basis, which differs from many organic psychiatric compounds, is a fundamental agent for mood stability. Lithium is used in the sustained management of major mood shifts.

Composition and Formulation: Lithium Carbonate

The sole active ingredient in Camcolit is Lithium carbonate. The compound is provided as a modified-release tablet or controlled-release formulation. This specific design is critical for safe and effective use, distinguishing it from immediate-release preparations.

The formulation allows for a gradual and controlled absorption of the lithium salt into the bloodstream. This slow-release mechanism is designed to maintain consistent therapeutic blood concentrations, which is vital for the drug’s function as a prophylactic agent. Therefore, the controlled-release nature helps ensure the body receives a steady, regulated supply of the active ingredient, making it particularly suitable for long-term therapeutic stability.

General Purpose of This Mood Stabilizer

The primary overall purpose of this antimanic agent is to stabilize mood by influencing communication within brain cells, contributing to emotional balance. It acts by modulating neurotransmitter activity and regulating complex intracellular signaling cascades.

By supporting these core neural functions, the agent helps dampen the physiological and emotional intensity associated with mood fluctuations. Its role is to stabilize CNS activity, assisting patients in maintaining long-term emotional equilibrium, such as when used to mitigate the frequency and severity of extreme mood cycles.

Regulatory References

  1. MedlinePlus Drug Information for Lithium

What side effects are possible with Camcolit?

The official safety profile for Lithium carbonate is structured around its potential effects on specific organ systems and the risk of concentration-dependent toxicity.

Official Frequency Classification of Adverse Reactions

Regulatory documents classify adverse reactions based on their observed occurrence:

  • Very Common: Affecting more than 1 in 10 individuals, these reactions typically include fine hand tremor, increased thirst (polydipsia), and increased urination (polyuria).
  • Common: Affecting 1 in 10 to 1 in 100 individuals, these reactions may include weight gain, fatigue, and transient nausea or diarrhea.
  • Uncommon/Not Known: Less frequent effects include hypothyroidism, goiter, leukocytosis, and certain cardiac conduction abnormalities.

System-Organ Class and Serious Reactions

The documented adverse reactions primarily affect the Renal and Urinary System (e.g., chronic impairment, Nephrogenic Diabetes Insipidus), the Endocrine System (e.g., thyroid changes), and the Nervous System. The most critical safety concern is Acute Lithium Toxicity, a serious adverse reaction characterized by severe neurological symptoms like confusion, muscle weakness, and potentially coma, which is directly tied to the drug's serum concentration.

Safety Patterns and Restrictions

Some safety patterns are associated with the duration of exposure. Gastrointestinal discomfort may occur transiently at treatment initiation, whereas effects like hypothyroidism and chronic renal changes are generally associated with long-term exposure. Safety restrictions include Contraindications against use in individuals with conditions like severe renal or cardiac disease, untreated Addison's disease, or conditions leading to sodium depletion (e.g., severe dehydration or a low-salt diet). The label also notes that older adults have a greater risk of toxicity.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory profile for Lithium carbonate overdose is defined by escalating severity based on serum lithium concentrations and the immediate need for medical intervention.

Overdose Scope Official Regulatory Statements
Documented Overdose Presentations Initial signs of toxicity include gastrointestinal effects (nausea, vomiting, diarrhea) and mild neuromuscular symptoms (fine hand tremor, mild ataxia, drowsiness). Severe toxicity manifests as coarse tremor, seizures, confusion, coma, and slurred speech.
Physiological Systems Affected Severe outcomes documented in official labeling include irreversible neurological damage, cardiovascular collapse, and renal failure.
Population-specific Overdose Notes The risk of toxicity is very high in patients with impaired renal function or conditions leading to dehydration or sodium depletion.
When Immediate Medical Help is Required Patients must seek immediate emergency assistance for symptoms like fainting, abnormal heart beats, or shortness of breath, and discontinue therapy for initial signs like vomiting or tremor.
Overdose Classifications (High-Level) Official Regulatory Statements
Severity Classification Toxicity is directly related to elevated serum concentrations, but signs may appear even within the therapeutic range in abnormally sensitive patients.
Overdose-Context Constraints No specific antidote is known. Management is symptomatic and supportive, often requiring intensive monitoring and dialysis for severe cases.

Connection to the overall overdose profile:

Regulatory documents mandate that any suspicion of overdose requires swift, immediate medical attention, as the toxicity profile can rapidly progress to life-threatening critical organ system failure. Given that no specific antidote exists, official management is centered on supportive care, the maintenance of physiological stability, and continuous observation in a hospital setting.

Therapeutic Uses of Camcolit

What Camcolit Treats: Main Uses and Benefits

Camcolit is primarily used as a mood-stabilizing agent for the sustained management of Bipolar Disorder (manic-depressive illness) and related Recurrent Affective Disorders. Its key therapeutic function is prophylactic, working to support the easing of severity and may assist with managing the frequency of extreme mood cycling. This is relevant in conditions characterized by periods of heightened symptoms and supports long-term emotional stability. In this context, it is used for the treatment of manic episodes and maintenance for Bipolar I Disorder.

The medicine is also applied in clinical settings that involve acute or unstable symptom patterns, specifically addressing Acute Manic Episodes. It is commonly used to help manage symptoms of increased neurological or muscular activity, such as motor hyperactivity, elation, and grandiosity. This assists with maintaining a sense of functional stability during episodes of heightened discomfort. Camcolit may be part of symptomatic management for disruptive behavioral symptoms like aggression and hostility that interfere with daily functioning. Additionally, it is used as an augmentation strategy for severe cases of treatment-resistant depression, contributing to easing discomfort when initial supportive relief was insufficient.

“This treatment provides supportive relief that helps patients cope more steadily during difficult episodes.”

Quick Fact: Relief for Mood Cycling

Camcolit is used in situations where symptoms cluster into patterns and supportive management is appropriate, particularly in conditions defined by recurring episodes of extreme mood fluctuation.

Eligibility and Restrictions for Use

Who Can and Cannot Use Camcolit?

The eligibility profile for Camcolit (Lithium Carbonate) is strictly defined by regulatory authorities and focuses on the body’s ability to safely process and excrete the medicine. These rules determine who may be treated and who must avoid use.


Contraindicated Populations

Camcolit is contraindicated and must not be used in the following populations, as stated in official labeling:

  • Patients with significant renal disease or severe renal impairment.
  • Patients with significant cardiovascular disease or known Brugada Syndrome.
  • Patients with severe dehydration or sodium depletion (hyponatremia).
  • Patients currently receiving diuretics or ACE inhibitors, due to high toxicity risk.

Eligibility by Age and Status

Population Group Regulatory Status
Adults Established use for approved indications.
Children under 7 Use is not recommended; safety is not established.
Older Adults Use requires caution due to increased risk of toxicity from potential renal impairment.
Pregnancy Restricted; generally should be withdrawn during the first trimester due to potential fetal harm.
Breastfeeding Contraindicated; lithium is excreted in human milk.

Use is established for adolescents and pediatric patients 7 years of age and older for Bipolar I Disorder.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents define the interaction profile of Lithium carbonate (Camcolit) through two primary domains: pharmacokinetic alteration of renal clearance and pharmacodynamic potentiation of neurotoxicity.

Pharmacokinetic Interactions: Altered Plasma Exposure

Co-administration with several medicinal product categories is officially documented to change the drug's concentration in the blood, primarily by reducing its renal clearance. This increases the risk of lithium plasma concentrations rising to toxic levels.

Interacting Substance Class Official Interaction Outcome
Diuretics (Thiazides, Loop) Reduced clearance, increased exposure
NSAIDs (Non-steroidal Anti-inflammatory Drugs) Reduced clearance, increased exposure
RASAs (ACE Inhibitors, ARBs) Reduced clearance, increased exposure

Pharmacodynamic and Substance Interactions

Regulatory warnings exist for combinations that may potentiate neurological effects:

  • Serotonergic agents (e.g., SSRIs, SNRIs) are associated with a heightened risk of Serotonin Syndrome.
  • Co-administration with certain antipsychotics (neuroleptics) increases the risk of severe neurologic adverse reactions.
  • The combination may prolong the effects of neuromuscular blocking agents.
  • Dietary sodium intake must remain stable; significant restriction or excess formally alters the drug's excretion rate, modifying its plasma exposure. In the Elderly Population, the risk from clearance-altering agents is heightened.

Mechanism of Action

Molecular Inhibition of Intracellular Enzymes

Camcolit primarily works by acting as a molecular inhibitor against two critical enzymes inside the brain's nerve cells: Inositol Monophosphatase ( IMPase) and Glycogen Synthase Kinase-3 beta ( GSK-3beta). This action fundamentally slows down specific intracellular signaling cascades, particularly those involved in phosphoinositide turnover and cell regulation. This action alters the kinetics and amplitude of specific intracellular signaling cascades.


Modulation of Neuronal Excitability

The active component, being an inorganic ion, modulates the flow and balance of sodium ions ( Na^+) across neuronal cell membranes. By subtly interfering with Na^+ transport systems, the drug alters the neuron's electrical potential. This physiological consequence is a direct reduction in the electrical volatility and firing propensity of individual nerve cells, thereby contributing to the stabilization of neural circuit activity.


Promotion of Neuroplasticity and Structural Modulation

The inhibitory effect on GSK-3beta results in activating pathways that promote long-term structural modulation and the establishment of new synaptic connections. This process, which involves upregulating factors like BDNF, encourages neurogenesis (new cell growth) and modulates the function of synaptic connections. This structural modulation contributes to the establishment of a sustained, long-term stabilized state within affective brain regions.

Dosage and Administration Information

Camcolit is an oral, controlled-release formulation of Lithium carbonate. Its administration is distinct from immediate-release forms because the tablet must be swallowed whole and must not be crushed, chewed, or broken to preserve the slow-release mechanism. The dose is typically taken twice daily in divided amounts, though a once-daily regimen may be implemented when the patient's concentration is stable.

Dosing is highly individualized and determined exclusively by Therapeutic Drug Monitoring (TDM), not by a fixed schedule. Plasma concentrations are measured from a blood sample taken 8 to 12 hours after the previous dose. Initial total daily doses for acute control often range from 1000 mg to 1800 mg, while long-term maintenance is commonly achieved with 900 mg to 1200 mg daily.

Special procedural conditions must be maintained throughout treatment, including adequate daily fluid intake and a normal, consistent salt diet. If a dose is missed, the standard protocol is to skip that dose and take the next scheduled dose; the dose must not be doubled. Older adults and patients with mild to moderate renal impairment require lower starting doses and slower adjustment due to changes in drug clearance. The treatment course is long-term, and discontinuation requires a gradual, monitored dose tapering.

Recent Clinical Evidence

Research evidence / Overview of studies for Camcolit

Evidence for Use in Bipolar Disorder Maintenance

This medicine was studied for its use in conditions characterized by fluctuating or episodic manifestations, focusing on long-term outcomes related to mood stability. The primary evidence base consists of systematic reviews and meta-analyses that combine data from multiple clinical trials, including long-term Randomized Controlled Trials (RCTs). These studies primarily monitored outcomes related to the recurrence of manic and depressive episodes over multi-year periods in adult populations.

Research describes patterns observed in the studies related to outcomes of manic episode recurrence over extended maintenance periods. In addition to mood outcomes, evidence derived from observational settings evaluating daily-life functioning has monitored outcomes related to suicide risk and overall mortality. Data show patterns related to these mortality outcomes that were observed over several years, contributing to the broader evidence landscape for long-term recurrent affective disorders.

Evidence for Use in Acute Manic Episodes

This compound was evaluated in short-term, placebo-controlled RCTs during research scenarios involving periods of heightened symptom activity. These studies explored short-term symptom changes, focusing on outcomes describing episodic or acute changes and endpoints related to symptom change severity. Populations included adults and adolescents (age 7-17). Studies report how symptoms evolved in the observed populations during the acute treatment phase.

Evidence Gaps and Areas of Uncertainty

Findings were mixed concerning the outcomes of depressive episode recurrence, which is not as consistently observed as the pattern seen for manic episodes. For the older adult population, evidence is limited, and studies focusing on the specific physiological strain or stress in this group remain insufficient. Research evidence is lacking for pediatric populations under the age of seven years, and outcomes were not established in this age group. Comparative evidence is lacking against certain alternative long-term treatments.

Key Studies & References

  1. Bipolar disorder: assessment and management (NICE Guideline CG185)

Frequently Asked Questions (FAQ)

Common questions about Camcolit (FAQ)


Q: Is Camcolit used for anything besides bipolar disorder?

A: Camcolit, which contains lithium carbonate, is officially indicated (approved) for the treatment of acute manic and mixed episodes and for long-term maintenance treatment in people with bipolar I disorder. Official product information confirms that general anxiety is not listed as an approved use.

Q: How quickly should I expect to feel the effects of Camcolit?

A: Studies and official information indicate that a therapeutic effect may be observed relatively soon after treatment initiation. In research involving patients with acute manic episodes, a normalization of symptoms was often reported within 1 to 3 weeks after the drug was started.

Q: Does Camcolit help with anxiety or just mood swings?

A: The approved uses for Camcolit are specifically focused on regulating and stabilizing mood, particularly in the context of bipolar disorder. General anxiety is not listed as a primary or approved indication for this medication in regulatory documents.

Q: Can Camcolit cause weight gain, and how common is it?

A: Yes, regulatory documents list weight gain as a common side effect of Camcolit. A common side effect means it may affect between 1 in 10 and 1 in 100 people taking the medicine.

Q: Are there any major foods or drinks I should avoid while on Camcolit?

A: Official patient information emphasizes the need to maintain adequate daily fluid intake and a normal, consistent salt (sodium) diet. Significant or sudden changes in your sodium or fluid consumption can change the concentration of the drug in your blood, potentially leading to problems.

Q: Can taking painkillers like ibuprofen interfere with Camcolit?

A: Yes, co-administration with a class of painkillers called NSAIDs (Non-steroidal Anti-inflammatory Drugs), which includes ibuprofen, can cause a drug interaction. Regulatory documents confirm that this interaction reduces the drug's clearance (how the kidneys remove it), which may cause levels to rise dangerously high.

Q: How long do most people need to take Camcolit?

A: Camcolit is typically intended for long-term or maintenance therapy to manage chronic mood stability. If the decision is made to discontinue the drug, official guidelines require that it be done through a gradual, monitored dose tapering (slowly reducing the amount).

Q: Is Camcolit safe to take if I'm also on an SSRI antidepressant?

A: Regulatory warnings state that combining Camcolit with serotonergic agents like SSRI antidepressants is associated with a heightened risk of developing Serotonin Syndrome. This is a serious neurological adverse reaction. Co-administration should only occur under strict medical oversight.

Q: Will Camcolit affect my ability to drive or operate machinery?

A: Regulatory documents advise that the drug can affect the ability to drive or operate machinery due to potential side effects like drowsiness, tremor, and psychomotor impairment. These effects should be considered before performing tasks that require full attention.

Q: Can older adults safely take Camcolit, and are there special concerns?

A: Yes, but with caution. Regulatory documents state that older adults have a greater risk of toxicity due to potentially reduced kidney function. Therefore, official guidance often suggests lower starting doses and a slower adjustment period for this group.

Q: What are the signs of a serious allergic reaction to Camcolit?

A: The most critical safety concern emphasized is Acute Lithium Toxicity, characterized by severe neurological symptoms like confusion and muscle weakness. While the label stresses this risk, signs of a general drug allergy may include swelling of the face or throat, hives, or a severe skin rash.

Q: What should I do if I experience severe vomiting or diarrhea while on Camcolit?

A: Severe vomiting or diarrhea can lead to dehydration and sodium depletion, which can cause dangerously high concentrations of the drug. Official safety guidelines for this situation indicate that the medication may need to be discontinued and that medical attention should be sought immediately.

Q: Does drinking coffee or other caffeine affect how Camcolit works?

A: Caffeine acts as a diuretic, meaning it can increase the rate at which the drug is excreted from the body. Because maintaining a steady concentration is critical, large changes in caffeine intake can impact the required dose and should be monitored.

Q: Is it true that Camcolit can cause a hand tremor?

A: Yes, official regulatory documents list a fine hand tremor as a very common side effect. This means it may affect more than 1 in 10 individuals taking the medication.

Q: Can I take herbal supplements like St. John's Wort while on Camcolit?

A: Official warnings exist for combining the drug with serotonergic agents, due to the risk of Serotonin Syndrome. Since many herbal products, like St. John's Wort, have serotonergic activity, they should be used only with professional medical supervision.

Q: Is there any research on Camcolit's effectiveness for preventing suicide?

A: Yes, the broader evidence base for this medicine goes beyond just mood stabilization. Official clinical study overviews mention that evidence derived from observational settings has monitored outcomes related to suicide risk and overall mortality over long-term periods.

Q: Can people with heart conditions take Camcolit?

A: The drug is officially contraindicated (must not be used) in patients with specific cardiac issues, including significant cardiovascular disease or a condition known as Brugada Syndrome.

Q: Does stopping Camcolit suddenly cause withdrawal symptoms?

A: The drug label requires that any discontinuation be done using a gradual, monitored dose tapering (slow reduction). This precaution is in place because abrupt cessation is strongly discouraged due to the risk of symptom relapse or other adverse effects.

Q: Are there any cosmetic side effects like hair loss linked to Camcolit?

A: Yes, official regulatory documents list alopecia (the medical term for hair loss) as a reported adverse dermatologic effect associated with the medication.

Q: What is the connection between Camcolit and acne?

A: Official adverse reaction reporting lists chronic folliculitis as a potential side effect. This condition can sometimes present with symptoms that resemble acne.

Q: Does Camcolit interact with blood pressure medications?

A: Yes, it interacts with certain common blood pressure medications. Specifically, drug interactions are documented for Diuretics (water pills) and RASAs (such as ACE Inhibitors and ARBs), as these can increase the concentration of the drug in the blood, raising the risk of toxicity.

Q: How often do the side effects of Camcolit go away after starting the medication?

A: The experience varies depending on the side effect. Official product information notes that certain gastrointestinal issues, like nausea or diarrhea, may occur transiently (temporarily) at the very start of treatment, but it does not give a timeline for all other side effects.

Q: Is Camcolit ever prescribed for children or teenagers?

A: Yes, regulatory status is established for adolescents and pediatric patients 7 years of age and older for Bipolar I Disorder. However, use is not recommended for children under the age of 7.

Q: Are there different formulations of Camcolit (e.g., immediate vs. slow release)?

A: Camcolit is specifically the modified-release or controlled-release formulation of lithium carbonate. This unique design is critical for maintaining steady drug levels and ensuring safe, effective use.

Q: Can being dehydrated be dangerous when taking Camcolit?

A: Yes, severe dehydration is listed as a contraindication because it is dangerous. Dehydration causes the kidneys to retain more of the drug, which can quickly lead to dangerously high blood concentrations and toxicity.

Q: Does Camcolit cause fatigue or drowsiness during the day?

A: Yes, both fatigue and drowsiness are listed as common side effects in the official adverse reaction data for this medication.

Q: Is there a link between Camcolit and memory problems?

A: Regulatory documents indicate that symptoms like impaired memory or confusion may be reported, particularly as a neurological symptom associated with chronic lithium toxicity in severe cases.

Q: Are there any vitamins or minerals that interact with Camcolit?

A: Yes, the balance of the mineral sodium (salt) in the body is critical. The official patient guide emphasizes that large changes in sodium intake can alter the drug's excretion rate, directly affecting its concentration in the blood.

Q: Is it common to have nausea when first starting Camcolit?

A: Yes, official adverse reaction data lists transient nausea as a common side effect. It is often experienced temporarily when the treatment is first initiated.

Q: Can a common cold or flu affect the way my body handles Camcolit?

A: Conditions that cause symptoms like excessive sweating, fever, or dehydration (often associated with cold or flu) can affect the body's electrolyte balance. Regulatory precautions warn that these changes can increase the risk of lithium toxicity.

Q: Does Camcolit affect blood sugar levels?

A: Yes, official adverse reaction reports indicate that the drug may occasionally affect blood glucose levels. Both hyperglycemia (high blood sugar) and, less frequently, hypoglycemia (low blood sugar) have been reported.

Q: Why is lithium carbonate used in Camcolit?

A: Lithium carbonate is the active ingredient in Camcolit. It is a unique inorganic salt preparation that is chemically different from many other psychiatric medications. It is the component that works within the central nervous system to stabilize mood and treat bipolar disorder.

Q: What are the long-term risks associated with taking Camcolit for many years?

A: Official regulatory documents identify certain side effects associated with long-term exposure. These generally include changes to the thyroid (such as hypothyroidism or goiter) and potential chronic changes in kidney function.

Q: Can women who are breastfeeding use Camcolit?

A: The official regulatory position is that the drug is generally contraindicated (not recommended) for women who are breastfeeding. This is because the active ingredient is known to be excreted into human milk.

Q: How important is it to take Camcolit at the exact same time every day?

A: It is critical to take doses in a regularly spaced manner because the drug's effectiveness depends on maintaining consistent therapeutic blood concentrations. This regulation is vital for long-term emotional stability.

Q: Are there any reports of vision changes related to Camcolit?

A: Yes, vision changes or visual disturbances have been reported as adverse reactions. Severe neurological symptoms like a headache combined with vision changes can be a sign of increased pressure around the brain.

Q: What information should I know about Camcolit before a surgical procedure?

A: Surgical procedures often involve a risk of dehydration or electrolyte imbalance, which can critically affect the drug's concentration in the body. For this reason, official precautions often advise that the medication be temporarily discontinued under medical guidance before major surgery.

Q: Is the feeling of being 'slowed down' a common side effect of Camcolit?

A: Related common side effects listed in official documents include fatigue and drowsiness. These effects may subjectively contribute to a feeling of being 'slowed down'.

Q: Can men who are planning to father a child take Camcolit?

A: While there is no known regulatory restriction related to female fertility, some sources indicate that the drug has a small chance of temporarily reducing sperm count in men.

How should Camcolit be stored and disposed of?

The official documentation for Camcolit (Lithium Carbonate) defines specific regulatory requirements for storage and disposal to maintain the medicine’s integrity and ensure safety.

Storage Requirements

  • Temperature: Do not store the medicine above 25 C.
  • Protection: The tablets must be kept in the original container and the container must be tightly closed to protect the product.
  • Child Safety: It is mandatory to keep the medicine out of the sight and reach of children.

Disposal Instructions

Official regulatory documents require that all unused or expired medicine be returned to a pharmacist for proper disposal. The medicine must not be discarded through household waste or disposed of in wastewater systems, such as drains or toilets.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Camcolit found in:

A-Z Index: